Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,707.2
6.8 (0.25%)

 

  • STI Straits Times Index
    2,707.2
    6.8 (0.25%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,561.8
    23.3 (1.52%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,366.3
    40.7 (0.17%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,919.3
    -4.1 (-0.14%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,695.7
    82.0 (0.36%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,916.7
    -24.3 (-0.49%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,438.7M
  • Value: 2,166.9M
  • Rise: 155
  • Fall: 187
  • Unch: 468

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Rex Intl0.187-0.005
ComfortDelGro1.570-0.040
Singtel2.580+0.010
ESR-REIT0.410+0.015
SPH1.370+0.010
NetLink NBN Tr1.020+0.035
3Cnergy0.024+0.001
CapitaMall Trust2.090-0.050
Mapletree Log Tr1.940-0.010
YZJ Shipbldg SGD1.010-0.010

World Indices

World Indices
Name Last Change
Nasdaq 9,682.9 +74.5
HSI 24,366.3 +40.7
HSCEI 9,967.9 +0.4
Jakarta 4,916.7 -24.3
Nikkei 225 22,695.7 +82.0
SSE Comp 2,919.3 -4.1
Shanghai A 3,060.0 -4.3
Shanghai B 205.7 +0.4
KOSPI 2,151.2 +4.2

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

Kalbe Farma Tbk. Kalbe Farma Tbk.
Quotes 10 Minutes Delayed. Updated at 04 Jun 2020 15:14
Last (IDR): 1,410.000 Change: -5.000 High: 1,440.000 Remarks: -
Change (%): -0.35 Low: 1,400.000
Open 1,440.000 Yesterday's Close 1415.000
Buy Price 1405.000 Sell Price 1410.000
Buy Volume ('000) 2,885.3 Sell Volume ('000) 66.5
Cumulative Volume ('000) 34,757.3 Cumulative Value 49,074,685,000
Click to show Stock Prices chart

Key Statistics

EPS (IDR) a 53.48001 Trailing EPS (IDR) e 55.06297 NAV (IDR) b 350.6807
PE a 26.365 Trailing PE f 25.607 Price / NAV b 4.0208
Dividend (IDR) d - Cash In Hand (IDR) g 83.7730 Issued & Paid-up Shares c 46,872,925,000
Dividend Yield (%) d - Price / Cash In Hand g 16.831 Treasury Shares h 2,175,000
Beta - 75 Daysi 1.037 R-Squared - 75 Days(%)i 38.92 Market Cap (M) 66,090,824.250
Beta - 500 Daysi 1.152 R-Squared - 500 Days (%)i 33.74 Enterprise Value (M) 64,008,718.128
Piotroski F Score 4 Exchange Code KLBF Par Value ( IDR ) 10.00000
52 Weeks Volatility (%) 43.57 6-Month VWAP 1287.842 Free Float (%) 42.8
Sector & Industry Health Technology - Pharmaceuticals: Other
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 04 May 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 04 May 2020.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference Kalbe Farma Tbk. IDX 66,090,824.250 26.365 25.607 4.0208 -
Industry Pharmaceuticals: Other IDX 23,179,819.850 28.002 27.187 4.0786 -
Local Peer Indofarma (Persero) Tbk. IDX 3,130,262.701 - - 6.4788 -
Local Peer Pyridam Farma Tbk IDX 318,372.600 34.077 34.077 2.4662 -
Global Peer CATALENT INC NYSE 12,243.138 92.751 117.949 5.5963 -
Global Peer ARGENX SE SPON ADR EACH REP 1 ORD SHS NASDAQ 9,849.799 - - 8.3511 -
Global Peer HORIZON THERAPEUTICS PLC NASDAQ 9,313.782 16.254 15.725 4.2561 -
Global Peer ICON PLC NASDAQ 8,899.191 23.796 23.581 5.8785 -
Global Peer FOSUN PHARMA HKEx 65,610.266 17.420 17.420 1.8427 1.665
Global Peer PERRIGO COMPANY PLC NYSE 7,570.824 51.819 40.142 1.3084 1.474
Global Peer BAUSCH HEALTH COMPANIES INC NYSE 6,775.286 - - 9.4233 -
Global Peer JAZZ PHARMACEUTICALS PLC NASDAQ 6,569.932 12.553 23.436 2.3393 -
Global Peer UNITED THERAPEUTICS CORP NASDAQ 5,532.346 - 10.482 1.8763 -
Global Peer MYOKARDIA INC NASDAQ 5,443.692 - - 15.5935 -
Other Global Peers GW PHARMACEUTICALS ADS EA REPR 12 ORD GBP0.00 (NASDAQ), LIVZON PHARMA (HKEx), BELLRING BRANDS INC (NYSE), AXSOME THERAPEUTICS INC (NASDAQ), AMARIN CORP ADR EACH REP 1 ORD GBP0.50 (NASDAQ), INTERCEPT PHARMACEUTICALS INC (NASDAQ), PRESTIGE CONSUMER HEALTHCARE INC (NYSE), REVOLUTION MEDICINES INC (NASDAQ), PACIRA BIOSCIENCES INC (NASDAQ), LUYE PHARMA (HKEx), SAGE THERAPEUTICS INC (NASDAQ), MADRIGAL PHARMACEUTICALS INC (NASDAQ), THERAVANCE BIOPHARMA INC (NASDAQ), CORCEPT THERAPEUTICS INC (NASDAQ), ZOGENIX INC (NASDAQ), HEC PHARM (HKEx), IRONWOOD PHARMACEUTICALS INC (NASDAQ), INNOVIVA INC (NASDAQ), PORTOLA PHARMACEUTICALS INC (NASDAQ), SUPERNUS PHARMACEUTICALS INC (NASDAQ), REVANCE THERAPEUTICS INC (NASDAQ), BLACKMORES LTD (ASX), TONG REN TANG (HKEx), MEGA (SET), SIHUAN PHARM (HKEx), ENDO INTERNATIONAL PLC (NASDAQ), AMPHASTAR PHARMACEUTICALS INC (NASDAQ), CLINUVEL PHARMACEUTICALS LTD (ASX), EAGLE PHARMACEUTICALS INC (NASDAQ), COLLEGIUM PHARMACEUTICAL INC (NASDAQ), AERIE PHARMACEUTICALS INC (NASDAQ), FUDANZHANGJIANG (HKEx), ASSEMBLY BIOSCIENCES INC (NASDAQ), OPTHEA LIMITED (ASX), Tianjin ZX USD (SGX), HUA HAN HEALTH (HKEx), BIODELIVERY SCIENCES INTERNATIONAL (NASDAQ), ANIKA THERAPEUTICS INC (NASDAQ), CATALYST PHARMACEUTICALS INC (NASDAQ), MEI PHARMA INC (NASDAQ), INTERSECT ENT INC (NASDAQ), ALBIREO PHARMA INC (NASDAQ), CONSUN PHARMA (HKEx), ANI PHARMACEUTICALS INC (NASDAQ), SHANDONG XINHUA (HKEx), MARINUS PHARMACEUTICALS INC (NASDAQ), AGILE THERAPEUTICS INC (NASDAQ), MALLINCKRODT PLC (NYSE), CERECOR INC (NASDAQ), ZYNERBA PHARMACEUTICALS INC (NASDAQ), GOLDEN THROAT (HKEx), JILIN CHANGLONG (HKEx), ACELRX PHARMACEUTICALS INC (NASDAQ), GALMED PHARMACEUTICALS LTD (NASDAQ), C HEALTH GP (HKEx), DOD (SET), CASSAVA SCIENCES INC (NASDAQ), OCI INTL (HKEx), CTI BIOPHARMA CORP (NASDAQ), ORAMED PHARMACEUTICALS INC (NASDAQ), ACASTI PHARMA INC (NASDAQ), SCYNEXIS INC (NASDAQ), YSPSAH (Bursa), ADAMAS PHARMACEUTICALS INC (NASDAQ), LONGRUN TEA (HKEx), HAPPINESS BIOTECH GROUP LTD (NASDAQ), QUALIGEN THERAPEUTICS INC (NASDAQ), VERONA PHARMA SPON ADR EACH REP 8 ORD SHS (NASDAQ), ACLARIS THERAPEUTICS INC (NASDAQ), ALTHEA GROUP HOLDINGS LTD (ASX), EVOKE PHARMA INC (NASDAQ), CUMBERLAND PHARMACEUTICALS INC (NASDAQ), NATURAL ALTERNATIVES INTERNATIONAL (NASDAQ), LIPOCINE INC (NASDAQ), ISORAY INC (NYSE American), TIANDA PHARMA (HKEx), NEOS THERAPEUTICS INC (NASDAQ), PLX PHARMA INC (NASDAQ), EAGLE HEALTH HOLDINGS LTD (ASX), TONIX PHARMACEUTICALS HLDG CORP (NASDAQ), BIOLINE RX LTD SPON ADS EACH REPR 15 ORD SHS (NASDAQ), AMPIO PHARMACEUTICALS INC (NYSE American), LANSEN PHARMA (HKEx), BOTANIX PHARMACEUTICALS LTD (ASX), IDT AUSTRALIA LIMITED (ASX), INTEC PHARMA LTD (NASDAQ), EYEGATE PHARMACEUTICALS INC (NASDAQ), ANTISENSE THERAPEUTICS (ASX), REGULUS THERAPEUTICS INC (NASDAQ), VITA LIFE SCIENCES LIMITED (ASX), PHARMAUST LIMITED (ASX), VIVUS INC (NASDAQ), HEPION PHARMACEUTICALS INC (NASDAQ), TETRAPHASE PHARMACEUTICALS INC (NASDAQ), SONOMA PHARMACEUTICALS INC (NASDAQ), CRONOS AUSTRALIA LIMITED (ASX), CANNPAL ANIMAL THERAPEUTICS LTD (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days 20.000+55.000
+5.54 %
10 Days 20.000+70.000
+6.72 %
20 Days 20.000+5.000
+1.78 %
Medium Term Return 3 Months 20.000+80.000
+7.52 %
6 Months 20.000-155.000
-8.63 %
1 Year 46.000+5.000
+3.63 %
Long Term Return 2 Years 71.000-55.000
+1.09 %
3 Years 93.000-160.000
-4.27 %
5 Years 112.000-275.000
-9.67 %
Annualised Return Annualised --
-2.01 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 830.000 - 1,690.000 Change From 1 Year Low +580.000 % Change From 1 Year Low (%) +69.88
Change From 1 Year High -280.000 % Change From 1 Year High (%) -16.57
2 Years Range 830.000 - 1,690.000 Change From 2 Years Low +580.000 % Change From 2 Years Low (%) +69.88
Change From 2 Years High -280.000 % Change From 2 Years High (%) -16.57
5 Years Range 830.000 - 1,815.000 Change From 5 Years Low +580.000 % Change From 5 Years Low (%) +69.88
Change From 5 Years High -405.000 % Change From 5 Years High (%) -22.31
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

PT Kalbe Farma Tbk engages in the development, distribution, and trading of pharmaceutical products. It operates through the following segments: Prescription Pharmaceutical, Consumer Health, Nutritionals, and Distribution and Logistic. The Prescription Pharmaceutical segment offers generic drugs, branded generics, and licensed drugs, which are distributed to hospitals, pharmacies, and drug stores. The Consumer Health segment includes over-the-counter drugs, consumer products, food supplements, preventive products, energy drinks, and healthy ready-to-drink products. The Nutritionals segment sells biscuits, cereals, and milk products for infants, toddlers, children, pre-teenagers, adults, expectant and lactating mothers, and elderly; as well as nutritional products for consumers with special medical needs. The Distribution and Logistic segment maintains distribution of the company's and third party principal's products across Indonesia; and focuses on the trading of raw material, medical devices, and retail health service. The company founded by Boenyamin Setiawan on September 10, 1966 and is headquartered in Jakarta, Indonesia.

Historical Price Data

Date Open High Low Close Volume VWAP
04 Jun 2020 1440.000 1440.000 1400.000 1410.000 34,757,300 1411.9245
03 Jun 2020 1395.000 1425.000 1385.000 1415.000 62,660,000 1409.7251
02 Jun 2020 1365.000 1425.000 1320.000 1385.000 63,506,700 1382.0369
29 May 2020 1360.000 1460.000 1355.000 1415.000 206,001,100 1415.5326
28 May 2020 1340.000 1365.000 1315.000 1355.000 35,733,300 1346.5976
27 May 2020 1330.000 1340.000 1310.000 1320.000 22,108,500 1324.9353
26 May 2020 1355.000 1360.000 1320.000 1325.000 35,300,400 1331.7161
20 May 2020 1400.000 1400.000 1315.000 1340.000 50,884,000 1333.8990
19 May 2020 1400.000 1405.000 1380.000 1390.000 38,331,600 1396.3241
18 May 2020 1400.000 1400.000 1380.000 1400.000 17,406,600 1395.0427
15 May 2020 1400.000 1400.000 1370.000 1400.000 25,213,800 1395.8644
14 May 2020 1400.000 1400.000 1370.000 1400.000 35,697,000 1396.8477
13 May 2020 1400.000 1405.000 1355.000 1400.000 20,203,800 1391.3175
12 May 2020 1385.000 1420.000 1360.000 1385.000 30,687,000 1386.7352
11 May 2020 1410.000 1415.000 1385.000 1385.000 33,331,300 1404.2988
08 May 2020 1405.000 1440.000 1380.000 1400.000 37,146,000 1400.1003
06 May 2020 1380.000 1415.000 1360.000 1405.000 55,190,700 1400.8788
05 May 2020 1405.000 1420.000 1355.000 1360.000 17,606,400 1371.5708
04 May 2020 1400.000 1425.000 1350.000 1380.000 46,895,400 1383.7895
30 Apr 2020 1470.000 1500.000 1415.000 1440.000 53,666,000 1444.5149
29 Apr 2020 1450.000 1480.000 1445.000 1470.000 52,010,200 1459.3781
28 Apr 2020 1345.000 1445.000 1320.000 1445.000 61,167,100 1387.5519
Summary
Current 2 Weeks
(18 May 2020 to 04 Jun 2020)
1400.000 1460.000 1310.000 1410.000 566,689,500 -
Previous 2 Weeks
(30 Apr 2020 to 15 May 2020)
1470.000 1500.000 1310.000 1400.000 355,637,400 -
4 Weeks from
(01 Apr 2020 to 29 Apr 2020)
1200.000 1460.000 1150.000 1470.000 1,093,082,900 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.